Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033774 (
pruritus
)
14,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Deficiency
of
Itch
, an E3 ubiquitin ligase, usually induced severe systemic and progressive autoimmune disease. The
Itch
function is well studied in T cells but not in B cells. We hypothesize that B-cell-specific
Itch
deficiency promoted antigen-induced B-cell activation and antibody-expressing plasma cell (PC) production. We found that unlike
Itch
KO,
Itch
cKO (CD19
cre
Itch
f/f
) mice did not demonstrated a significant increase in the sizes of spleens and LNs, antibody level, and base mutation of antibody gene. However, in line with the fact that
Itch
expression decreased in GC B cells, PCs, and plasmablast (PB)-like SP 2/0 cells,
Itch
deficiency promoted B-cell activation and antibody production induced by antigens including lipopolysaccharide (LPS) and sheep red blood cells (SRBCs). Mechanistically, we found that
Itch
deficiency promotes antigen-induced cytokine production because
Itch
controls the proteins (e.g., eIF3a, eIF3c, eIF3h) with translation initiation factor activity. Altogether, our data suggest that
Itch
deficiency promotes antigen-driven B-cell response. This may provide hints for
Itch
-targeted treatment of patients with autoimmune disease.
...
PMID:The E3 ubiquitin ligase Itch deficiency promotes antigen-driven B-cell responses in mice. 3265 69
<< Previous
1
2
3
4
5